selected publications
- PD-1/PD-L1 for prostate cancer: from clinical trials to practice. Expert review of clinical pharmacology. 2026 Information Resource GET IT
-
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
Blood.
2026
Academic Article
GET IT
Times cited: 2 -
Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy.
Expert opinion on investigational drugs.
2025
Information Resource
GET IT
Times cited: 1